Call Us With No Obligation
(877) 446-9001
24 Hours/ 7 days a week

Contact us to start your claim today



Fentanyl (Duragesic)MethadoneOxyContin (oxycodone)Vicodin (hydrocodone)Dilaudid (hydromophone)Other

captcha

Yes I agree to the Terms & Conditions

Posts Tagged ‘overdose’

Drugmakers blocking opioid painkillers marketing investigation, New Hampshire attorney general says

Monday, August 22nd, 2016

New Hampshire attorney general Joe Foster has accused five drug companies of blocking a statewide probe into whether the drugmakers broke the law in their marketing of opioid painkillers such as OxyContin. Foster says that the investigation could result in a state lawsuit against the drug companies if they are found to have violated New Hampshire laws by downplaying the addiction risk of opioid medications. (more…)

New studies warn of ‘suboptimal’ prescribing practices for opioid painkillers at U.S. hospitals

Monday, June 20th, 2016

Two new studies published by the journal JAMA Internal Medicine have found that improper prescribing practices on the part of doctors and hospitals may be putting patients at risk of dependency and other complications from opioid painkillers. According to the reports, these “suboptimal” practices increase the risk of dependency for patients who are prescribed opioids, which could increase their risk of addiction or overdose. (more…)

Opioid painkillers overprescription ‘one of the great mistakes of modern medicine’ says former FDA chief

Tuesday, May 17th, 2016

The former head of the Food and Drug Administration says that the dramatic increase in the prescription of opioid painkiller medications in recent decades is “one of the great mistakes of modern medicine.” Dr. David Kessler ran the FDA from 1990 through 1997, around the time that the current epidemic of opioid painkillers overprescription began. (more…)

FDA issues black box warning for opioid painkillers to curb overdose, addiction risks

Monday, March 28th, 2016

The Food and Drug Administration has announced that it will require a “black box” warning on the most widely prescribed class of opioid painkillers in an effort to curb the epidemic of fatal overdoses linked to these drugs. The new FDA warning will be required for all immediate-release opioid painkillers, including combination pills that combine opioid medications with non-prescription drug ingredients. (more…)

FDA plans new opioid painkiller approval rules following Senate fight over new commissioner nomination

Thursday, February 11th, 2016

The Food and Drug Administration has announced that it will overhaul its review process for opioid painkiller drugs. The announcement came following pressure from three U.S. Senators who had blocked the approval process of Robert Califf, who was nominated to lead the FDA by President Obama. (more…)

Painkillers are the leading cause of death among male patients taking high dose opioids, study reveals

Monday, December 21st, 2015

A large scale study of patients in Ontario, Canada has found that one in four male patients taking high dose opioid painkillers later died as a result of opioid-related causes. Dr. David Juurlink, a physician involved with the study, said that these results underscored the importance of restricting the use of powerful opioid painkillers like fentanyl and oxycodone in order to reduce the risk of overdose and other complications for patients. (more…)

FDA approves new abuse-resistant OxyContin-alternative drug Targiniq ER

Monday, August 18th, 2014

The Food and Drug Administration has approved a new form of the painkiller OxyContin designed to limit the potential for abuse and curb the number of overdose deaths caused by the drug. The new drug, Targiniq ER, is made by Perdue Pharma. It combines the active painkiller ingredient oxycodone with naloxone, a medication which is used to reverse the effects of an opioid overdose. (more…)